Melphalan hydrochloride and Memory loss - a phase IV clinical study of FDA data
Summary:
Memory loss is reported as a side effect among people who take Melphalan hydrochloride (melphalan hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Multiple myeloma.
The phase IV clinical study analyzes which people have Memory loss when taking Melphalan hydrochloride. It is created by eHealthMe based on reports of 3,963 people who have side effects when taking Melphalan hydrochloride from the FDA, and is updated regularly.
What is Melphalan hydrochloride?
Melphalan hydrochloride has active ingredients of melphalan hydrochloride. eHealthMe is studying from 3,970 Melphalan hydrochloride users. Check the latest studies of Melphalan hydrochloride.
What is Memory loss?
Memory loss is found to be associated with 2,726 drugs and 4,377 conditions by eHealthMe. Check the latest studies of Memory loss.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
3,963 people reported to have side effects when taking Melphalan hydrochloride.
Among them, 56 people (1.41%) have Memory loss.

Among these 56 people:
How long have people been on Melphalan hydrochloride when they have Memory loss? *
- < 1 month: 56.25 %
- 1 - 6 months: 31.25 %
- 6 - 12 months: 12.5 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Memory loss when taking Melphalan hydrochloride? *
- female: 28.3 %
- male: 71.7 %
What is the age of people who have Memory loss when taking Melphalan hydrochloride? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 24.24 %
- 30-39: 0.0 %
- 40-49: 12.12 %
- 50-59: 18.18 %
- 60+: 45.45 %
What are other drugs people take besides Melphalan hydrochloride? *
- Zometa: 32 people, 57.14%
- Aredia: 23 people, 41.07%
- Famotidine: 17 people, 30.36%
- Coumadin: 16 people, 28.57%
- Dexamethasone: 16 people, 28.57%
- Lisinopril: 16 people, 28.57%
- Atenolol: 14 people, 25.00%
- Simvastatin: 13 people, 23.21%
- Cozaar: 13 people, 23.21%
- Tacrolimus: 13 people, 23.21%
What are other side effects people have besides Memory loss? *
- Pain: 36 people, 64.29%
- Nausea (feeling of having an urge to vomit): 32 people, 57.14%
- Osteonecrosis Of Jaw (death of bone of jaw): 30 people, 53.57%
- Stress And Anxiety: 26 people, 46.43%
- Nausea And Vomiting: 25 people, 44.64%
- Pneumonia: 25 people, 44.64%
- Constipation: 24 people, 42.86%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 23 people, 41.07%
- Chest Pain: 22 people, 39.29%
- Dizziness: 21 people, 37.50%
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 34 people, 60.71%
- Bone Marrow Conditioning Regimen: 11 people, 19.64%
- White Blood Cell Count Abnormal: 5 people, 8.93%
- Ewing's Sarcoma Recurrent (malignant small, round, blue cell tumour- recurrent): 5 people, 8.93%
- High Blood Pressure: 5 people, 8.93%
- Anaemia (lack of blood): 3 people, 5.36%
- Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 3 people, 5.36%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 5.36%
- Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 2 people, 3.57%
- Metastases To Bone (cancer spreads to bone): 1 person, 1.79%
* Approximation only. Some reports may have incomplete information.
Do you take Melphalan hydrochloride and have Memory loss?
- Check whether Memory loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Melphalan hydrochloride:
- Melphalan hydrochloride (3,970 reports)
Memory loss treatments and more:
- Memory loss (244,444 reports)
How severe was Memory loss and when was it recovered:
Expand to all the drugs that have ingredients of melphalan hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Melphalan hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Memory loss:
- Memory loss (2,726 drugs)
Browse all the conditions that are associated with Memory loss:
- Memory loss (4,377 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on melphalan hydrochloride (the active ingredients of Melphalan hydrochloride) and Melphalan hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Decadron and Keppra drug interactions for women aged 60+ - a second ago
- Zide and Limb Injury for Women aged 60+ - 2 seconds ago
- Vaginal Bleeding Between Periods and drugs of ingredients of melatonin - 3 seconds ago
- Could Dipyrone cause Oral Candidiasis? - 6 seconds ago
- Could Atenolol cause Glycosylated Haemoglobin? - 8 seconds ago
- Zometa and Gastroesophageal Reflux Disease for Women aged 50-59 - 8 seconds ago
- Zometa and Gastrooesophageal Reflux Disease for Women aged 50-59 - 9 seconds ago
- Zometa and Gastro-Oesophageal Reflux Disease for Women aged 50-59 - 9 seconds ago
- Zometa and Reflux for Women aged 50-59 - 9 seconds ago
- Zometa and Heartburn for Women aged 50-59 - 10 seconds ago